Cytospire Therapeutics
Altrincham
About Cytospire Therapeutics
Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers.
Company Facts
- Legal name: Cytospire Therapeutics Ltd.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $82.6M
- Funding stage: Seed
- Last round: Seed (Jan 2023)
- Website: cytospire.com
Social Profiles
Canonical: https://fsome.com/organization/cytospire-therapeutics-8385039 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.